Research and Markets has announced the addition of the "Biopsy Needles Market - Forecast (2016-2022)" report to their offering.

Biopsy needles can be defined as a medical instrument used to perform a biopsy, which is a procedure to obtain a sample of cells from your body for laboratory testing. Common needle biopsy procedures include fine-needle aspiration and core needle biopsy. Needle biopsy may be used to take tissue or fluid samples from muscles, bones, and other organs, such as the liver or lungs. Globally, increasing prevalence of cancer and increasing healthcare spending are expected to drive the demand for biopsy needles during the period of study.

Geographically, North America dominated the biopsy needles market driven by world class healthcare infrastructure with a technologically advanced practice, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for biopsy needles market.

Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.

Companies Mentioned:

  • Medax Medical Devices
  • Creganna Medica
  • Angiotech
  • Argon Medical devices
  • Cardinal Health, Inc.
  • Carefusion Corporation
  • C.R. Bard, Inc.
  • DTR Medical
  • Hologic, Inc.
  • INRAD, Inc.

Key Topics Covered:

1. Market Overview

2. Executive Summary

3. Market Landscape

4. Market Forces

5. Strategic Analysis

6. Biopsy needles Market, By Type

7. Biopsy needles Market, By Cancer Type

8. Biopsy needles Market, By Geography

9. Market Entropy

10. Company Profiles

11. Appendix

For more information about this report visit http://www.researchandmarkets.com/research/rjm8fg/biopsy_needles